TrackPaw Scientific AB

TrackPaw Scientific AB 🤝 Lightbringer! As a startup, efficient resource allocation is critical. We recognised the importance of establishing a solid intellectual property (IP) strategy and securing patent protection to safeguard our innovations early on, and searched for a solution that could streamline this process. We've been using Lightbringer's tool for the past couple of quarters which yielded two more patents to our portfolio. We are happy to have such a versatile and intuitive tool that adds great value to our ever growing IP portfolio!

Almi Invest Digital Demo Day 2024 – Vilken succé! I onsdags samlade vi ett rekordantal med över 200 investerare som fick möjligheten att se nio av våra spännande portföljbolag pitcha sina affärsidéer. Allt skedde digitalt och vi är otroligt stolta över engagemanget och den positiva responsen från både startups och investerare. Event som Digital Demo Day är en viktig del av vårt uppdrag på Almi Invest – att stötta innovativa bolag på deras tillväxtresa och skapa mötesplatser där entreprenörer och investerare kan knyta värdefulla kontakter. Vi vill tacka alla som deltog och gjorde detta till ett inspirerande event. Ta gärna en titt på vår korta film från eventet och se hur vi tillsammans jobbar för att forma framtidens företag! 🚀 #AlmiInvest #Almi

Meet us at NLS Nordic Days in Malmö (September 18-19)! Trackpaw Scientific's one and only Lotte Martoft will be attending #NLSDays, and she's looking forward to making meaningful connections with professionals in preclinical research, animal welfare, and #CROs. Talk to her about the future of in-cage monitoring systems, advancements in animal welfare, the #3Rs, and data-driven preclinical research with her. Lotte, a key contributor to the development of TrackPaw’s cutting-edge solutions, brings a wealth of knowledge in drug development and is excited to share her insights. Make sure to connect with her!

We keep expanding! Celebrating our return to the office by welcoming our newest team member - Carl Johan Wetterqvist! 📣 Carl Johan joins us as Lead Software Engineer, bringing extensive experience in software development, architecture, and agile project leadership from working as a consultant at companies like Kodify, Bouvet and Stratiteq. He's a problem-solver at heart, with a hands-on approach to tackling complex challenges with a customer-oriented focus. He has already become a key player in our mission to deliver a software that is easily implemented at our customer sites. Welcome to the team, Carl Johan! Seen in photo: Carl Johan and our office wellness coach Nala.

We are thrilled to welcome Martin Carlström to our team as a Software Developer! Martin holds a degree in Engineering Physics and brings a wealth of experience in full-stack development, computer science, algorithm development, and product design. He will play a vital role in our efforts to create a great experience for our customers during the beta launch later this year. Martin's curiosity knows no bounds; he loves to dive and free-dive in his spare time! 🌊 Welcome to the TrackPaw team, Martin!

Next week, TrackPaw Scientific AB will take part in the annual Scandinavian Society for Laboratory Animal Science (Scand-LAS) conference in Tampere, Finland! 🐁 Make sure to catch our abstract presentation “Detection of male-mouse incompatibility in research studies using an automated in-home cage monitoring system (the TRACK-system)”, on the 23rd of May at 4:50 PM! This abstract is based on collaborative efforts in creating a vital functionality for our in-home cage monitoring system. Scroll down in the scientific programme to find our abstract 👇 https://lnkd.in/diM5B6KU We hope to see you there! #Scandlas #preclinical #drugdevelopment

TrackPaw Scientific AB announces the close of its pre-seed round of 6.6 MSEK (591 000 €). The round, led by Almi Invest was partly closed in October 2023 and the company is now very happy to welcome ERM Invest and its clinical development veteran Ola Gudmundsen as a new anchor investor in TrackPaw! Ola holds a PhD in physiology and is well-known as the founder of the clinical CRO Link Medical AS, where he was the CEO until 2023. Ola has long experience in the drug developmental landscape, primarily in clinical trials and business development. ‘’We are honoured to have received such great support from our investors, who all harbour relevant expertise in the field of life science and technology. It comes to show that our mission of providing solutions for data-driven, efficient and automated monitoring of animal welfare and behavior during pharmaceutical development is shared by many’’ CEO Liza Tchapanova Albrektson says. The work towards a beta launch of the surveillance system during the fall of 2024 now commences at full speed, along with an further expansion of the IP portfolio. #Drugdevelopment #preclinical #3R #TrackpawScientific

Are you a Backend or Electronics Engineer? 👩💻 👨💻 Hear Liza give a brief overview of our mission and call for new teammates to join our huddle. Click the link below to apply to one of our full-time positions! https://lnkd.in/dE34N6BN #backend #fullstack #electronics #hiring

We're kicking #2024 off with #job #opportunities! We currently have two positions where we are actively recruiting: 1. #Electronics Engineer 2. #Backend Engineer In short, you'll be able to: 🤝 Being part of a tight-knit team with established connections to the life science industry. 📊 Have the possibility to participate in a stock option program. 💡 Being part of a highly flexible work environment with lots of support from surrounding companies and our internal advisors. We look forward to receive your application. Click the link below to apply with your #CV. #biotech #deeptech #drugdevelopment https://lnkd.in/dE34N6BN

Happy Holidays from TrackPaw Scientific AB!🔬 As our mission at Trackpaw is to drive the development of safe and effective pharmaceuticals by digitalising the preclinical landscape, we're very pleased to have seen the paradigm shift opting for digital preclinical studies truly skyrocketing in 2023. We're delighted to share our key highlights: 📄 Patent Pending: We filed for our first patent, safeguarding key hardware innovations and their applications. 🤝 Board Expansion: We had the pleasure of welcoming prominent figures in life sciences and distribution experts to our board, fortifying our strategic guidance for 2024's commercial activities. 🚀 Team Expansion: Our team grew with brilliant minds in electronics engineering, mechanical engineering, and system architecture, steering the development of our beta version prototype which will be launched in 2024. 🌐 Successful Pilot Trial: We're happy to share that our first customer-based pilot trial yielded satisfying results in an end-user environment, paving the way for continued projects! 👥 Nurturing our partnerships: With several global site visits with end users in the bag, we've aligned our product development with the real needs of the market. 💼 Successful pre-seed round: Last but not least - Welcoming new owners to our cap table, which not only fuels our 2024 initiatives but also motivates our daily operations. We are truly gaining speed, and are thankful for the support given by stakeholders, collaborators and future customers. We wish you all joyous celebrations and a fantastic New Year! 🎄 #preclinical #drugdevelopment #deeptech #3R